Serum TSH level as a predictor of thyroid cancer in patients with newly diagnosed thyroid nodule.
Not Applicable
Completed
- Conditions
- Health Condition 1: C73- Malignant neoplasm of thyroid gland
- Registration Number
- CTRI/2021/10/037654
- Lead Sponsor
- Amrita Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 304
Inclusion Criteria
All euthyroid patients who underwent thyroid surgery for newly diagnosed thyroid nodules with FNAC reported as indeterminate cytology (Bethesda III) were included in our study.
Exclusion Criteria
Patients, other than Bethesda class III or those already diagnosed with thyroid malignancy were excluded from the study. Other exclusion criteria were patients on thyroid hormone supplementation and Serum TSH level not within the euthyroid range.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method